CF PHARMTECH (02652) spent 962,500 Hong Kong dollars to repurchase 27,500 shares on February 13th.
Changfeng Pharmaceutical (02652) announced that it will spend 962,500 Hong Kong dollars to repurchase 27,500 shares on February 13, 2026.
CF PHARMTECH (02652) announced on February 13, 2026, that it will spend 962,500 Hong Kong dollars to repurchase 27,500 shares.
Related Articles
New stock news | Plais Pharmaceuticals submits application to Hong Kong Stock Exchange.
New Stock News | Novartis Bio submits application to Hong Kong Stock Exchange
I.CENTURY HLDG(08507): Golden Road & Castle appointed as the auditor
New stock news | Plais Pharmaceuticals submits application to Hong Kong Stock Exchange.
New Stock News | Novartis Bio submits application to Hong Kong Stock Exchange
I.CENTURY HLDG(08507): Golden Road & Castle appointed as the auditor
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
